SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-024429
Filing Date
2021-05-04
Accepted
2021-05-04 11:10:55
Documents
3
Period of Report
2021-05-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140319-8k_inmedpharma.htm 8-K 32870
2 NEWS RELEASE, DATED MAY 4, 2021 ea140319ex99-1_inmedpharma.htm EX-99.1 7844
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5343
  Complete submission text file 0001213900-21-024429.txt   49318
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 21886761
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences